Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 190 for “"Hydroxydopamine"”.

  1. Exercise-induced neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model

    … of exercise, both forced and voluntary, in a 6-hydroxydopamine-induced hemiparkinsonian rat model. The research approach adopted in this dissertation included a randomized control design of forced and voluntary exercise (i.e., treadmill and running wheel) applied before and after …

    unlv Repository record for Exercise-induced neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model (opens in a new tab) Download PDF for Exercise-induced neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model (opens in a new tab)

  2. The molecular mechanisms underlying 6-hydroxydopamine and ethanol-induced neurotoxicity

    Ethanol and 6-hydroxydopamine (6-OHDA), a Parkinson's disease (PD) mimetic, are two toxins to the cerebellum. This study investigated the molecular mechanisms underlying their neurotoxicities. The work in chapter 2 of this thesis focused on 6-OHDA-induced neurodegeneration. Previous studies …

    wvu Repository record for The molecular mechanisms underlying 6-hydroxydopamine and ethanol-induced neurotoxicity (opens in a new tab)

  3. Effects of 6-hydroxydopamine on plasma gonadothrophin levels in male rats

    … given a single intraventricular injection of 6-hydroxydopamine hydrochloride (6-ODHA; 170 μg free base) dissolved in 0.001 N HCl. Plasma LH and FSH were measured by double antibody radioimmunoassay. LH in the 6-OHDA treated animals was significantly reduced after one hour and remained …

    mcmaster Repository record for Effects of 6-hydroxydopamine on plasma gonadothrophin levels in male rats (opens in a new tab)

  4. Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine pretreated rats

    … with either vehicle (VEH) or the neurotoxin 6-hydroxydopamine (6-OHDA). Subsequently all rats were given an acute injection of one of the three clonidine doses (0.001, 0.01, 0.1 mg/kg), an alpha-2 agonist, or saline 30 minutes prior to each kindling trial.The 6-OHDA pretreatment facilitated the …

    carleton Repository record for Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine pretreated rats (opens in a new tab)

  5. Examination of melatonin receptor expression in the 6-hydroxydopamine rat model of Parkinson’s disease

    … hydroxylase (TH) immunoreactivity in a 6-hydroxydopamine (6-OHDA) model of PD. We also have reported that transplantation of MT1 receptor-expressing mouse neural stem cells (C17.2) along with melatonin treatment, preserved TH immunoreactivity in a similar PD model. Moreover, others have …

    mcmaster Repository record for Examination of melatonin receptor expression in the 6-hydroxydopamine rat model of Parkinson’s disease (opens in a new tab)

  6. Determination of the Acute Neurotoxic Effects of 6-Hydroxydopamine on Dopamine Transmission and Locomotive Behaviors

    … to DA neurodegeneration. The neurotoxin 6-hydroxydopamine (6-OHDA) has been widely used to generate animal models of Parkinson’s disease to study cellular and molecular mechanisms, including production of ROS, underlying selective degeneration of DA neurons. However, its acute mechanisms of …

    buffalo Repository record for Determination of the Acute Neurotoxic Effects of 6-Hydroxydopamine on Dopamine Transmission and Locomotive Behaviors (opens in a new tab)

  7. Factors Contributing to Weight Loss Induced by Intraventricular 6-Hydroxydopamine Lesions in Diabetes (db/db) Mice.

    … produced by intraventricular infusion of 6-hydroxydopamine (6-OHDA) in the db/db mouse results in significant weight loss and decreased blood glucose levels. The purpose of this study was to examine both long and short term effects of central NE depletion in db/db mice and to evaluate some …

    uab Repository record for Factors Contributing to Weight Loss Induced by Intraventricular 6-Hydroxydopamine Lesions in Diabetes (db/db) Mice. (opens in a new tab)

  8. A transthyretin-related gene and a neuroligin-like gene prevent 6-hydroxydopamine-induced dopaminergic neurodegeneration in <i>C. elegans</i>

    … neurons from oxidative stress inflicted by 6-hydroxydopamine (6-OHDA) uptake and isolated the neuroligin-like gene <i>glit-1</i> and the transthyretin-related gene <i>ttr-33</i>. Neuroligins are transmembrane proteins involved in the development and function of synapses. We provide evidence …

    dundee Repository record for A transthyretin-related gene and a neuroligin-like gene prevent 6-hydroxydopamine-induced dopaminergic neurodegeneration in <i>C. elegans</i> (opens in a new tab) Download PDF for A transthyretin-related gene and a neuroligin-like gene prevent 6-hydroxydopamine-induced dopaminergic neurodegeneration in <i>C. elegans</i> (opens in a new tab)

  9. EFFECTS OF A UNILATERAL INTRASTRIATAL 6-HYDROXYDOPAMINE MODEL OF EARLY PARKINSON'S DISEASE ON MIDBRAIN DOPAMINE NEURONS IN RATS: A STEREOLOGICAL STUDY

    … investigated in the unilateral intrastriatal 6-hydroxydopamine (6-OHDA) model of early to moderate Parkinson's disease in Aim 1. In addition, a method was developed to use a novel staining method combining tyrosine hydroxylase (TH) staining with silver nucleolar (AgNOR) staining and …

    ku Repository record for EFFECTS OF A UNILATERAL INTRASTRIATAL 6-HYDROXYDOPAMINE MODEL OF EARLY PARKINSON'S DISEASE ON MIDBRAIN DOPAMINE NEURONS IN RATS: A STEREOLOGICAL STUDY (opens in a new tab)

  10. Tumor Necrosis Factor Dependent Mechanisms and Neuroprotective Strategies in Models of Parkinson's Disease

    … tumor necrosis factor inhibitor reduced 6-hydroxydopamine-induced nigral degeneration by 50% and attenuated amphetamine-induced rotational behavior, indicative of striatal dopamine preservation in a rodent model of Parkinson's disease. Similar protective effects were observed with in vivo …

    utswmed Repository record for Tumor Necrosis Factor Dependent Mechanisms and Neuroprotective Strategies in Models of Parkinson's Disease (opens in a new tab)

  11. Investigating group III metabotropic glutamate receptors as novel therapeutic targets in Parkinson’s disease and Levodopa-induced dyskinesia

    … the SNc as a neuroprotective approach in the 6-hydroxydopamine lesioned rat; however while one mGlu4 positive allosteric modulator tested was successful another was not, highlighting several future considerations for the use of these agents. Unexpectedly, activation of group III and mGlu4 …

    kings Repository record for Investigating group III metabotropic glutamate receptors as novel therapeutic targets in Parkinson’s disease and Levodopa-induced dyskinesia (opens in a new tab) Download PDF for Investigating group III metabotropic glutamate receptors as novel therapeutic targets in Parkinson’s disease and Levodopa-induced dyskinesia (opens in a new tab)

  12. CATECHOLAMINE REGULATED PROTEIN 40 (CRP40): CLINICAL IMPLICATIONS IN PARKINSON’S DISEASE

    … and, upon injection at the striatum of 6-hydroxydopamine hemi-lesioned rats, alleviates behavioural symptoms for up to 7 days. On the other hand, a 7kDA fragment of CRP40 does not bind dopamine, but does confer the same alleviatory effect upon intra-striatal injection in 6-hydroxydopamine …

    mcmaster Repository record for CATECHOLAMINE REGULATED PROTEIN 40 (CRP40): CLINICAL IMPLICATIONS IN PARKINSON’S DISEASE (opens in a new tab)

  13. Effect of depletion of noradrenaline on cortical kindling

    … rats pretreated with bilateral injections of 6-hydroxydopamine (6-OHDA) into the mesencephalic trajectory of the dorsal tegmental noradrenergic bundle. Extensive depletion of forebrain noradrenaline (arbitrarily defined as greater than 80%) significantly facilitated the rate of kindling of …

    uvic Repository record for Effect of depletion of noradrenaline on cortical kindling (opens in a new tab)

Page 1 of 10